Sanofi Innovation Award 2024

Novel Approaches in Type 2 Inflammation

Awarded to the Project Leaders: Lukas Jörg¹, Daniel Yerly¹,²
In Collaboration with: Anna Gschwend¹, Lester Thoo², Werner Pichler², Oliver Hausmann²,³, Susanne Radonjic⁴

Affiliations:
¹ Division of Allergology and Clinical Immunology, Department of Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
² ADR-AC GmbH, Adverse Drug Reactions – Analysis and Consulting, Bern, Switzerland
³ Löwenpraxis, Luzern, Switzerland
⁴ Department of Dermatology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland

For the Project:

Deciphering Drug-Induced Maculopapular Exanthema through Cytokine Profiling in the Acute and Resolution Stages of Delayed Drug Hypersensitivity Reactions

This award, sponsored by Sanofi, is endowed with CHF 10’000 and is intended for the execution of a scientific project.

sanofi-aventis (schweiz) ag
3, route de Montfleury
CH – 1214 Vernier